Review payments information by May 15

Review payments information by May 15

Doctors of optometry have less than a month remaining to review—and challenge, if they choose to—their public-reported data and updates on payments made to them during 2016 by drug and medical device manufacturers.

The data for review for doctors of optometry is provided by drug and medical device manufacturers and group purchasing organizations.

According to the Centers for Medicare & Medicaid Services' (CMS') Open Payments transparency program, the 45-day review period began April 1. After the review period, CMS will publish the 2016 data on June 30 on its website. CMS also will publish updated data for the 2013, 2014 and 2015 program years.

The data for review for doctors of optometry is provided by drug and medical device manufacturers and group purchasing organizations.

"Physician and teaching hospital review of the data is voluntary, but strongly encouraged," CMS says. "While the opportunity for (them) to dispute any data associated with them expires at the end of the calendar year in which the record is published, the dispute must be initiated during this 45-day review and dispute period, ending on May 15, in order to be reflected in the June 30 publication."

Part of the Affordable Care Act (ACA), the Open Payments system requires drug and device makers and group purchasing organizations to disclose payments or gifts to doctors of optometry and other doctors on an annual basis. CMS collects and creates the database so members of the public can be aware of these financial relationships.

Publicly reported payments received by doctors include:

  • Cash or cash equivalent.
  • In-kind items or services.
  • Stocks, or stock options, or any other ownership interest, dividend, profit, or other return on investment.
  • Any other form of payment or other transfer of value.

Gifts might include travel and lodging, grants, consulting fees, honorarium, education, and food and beverages.

The system is meant "to increases public awareness of financial relationships between drug and device manufacturers and certain health care providers," according to CMS.

What doctors of optometry need to know
To review their data, doctors must be registered in CMS' Enterprise Identity Management and Open Payments systems. To learn more about the Open Payments review and dispute process, doctors can visit the CMS' review and dispute process web page or access the AOA alert on Open Payments. Doctors can contact AOA regulatory policy specialist Jensen Jose in the AOA's Washington office at JJose@aoa.org if they have questions or problems with disputed data.

April 20, 2017

comments powered by Disqus